Seronegative myasthenia gravis. Evidence for plasma factor(s) interfering with acetylcholine receptor function.
Department of Clinical Neurology, University of Oxford, United Kingdom.
A
A
Vincent
Z
Z
Li
A
A
Hart
R
R
Barrett-Jolley
T
T
Yamamoto
J
J
Burges
D
D
Wray
N
N
Byrne
P
P
Molenaar
J
J
Newsom-Davis
D000109:Acetylcholine / Q000378:metabolism; D001323:Autoantibodies / Q000276:immunology; D002217:Carbachol / Q000494:pharmacology; D002478:Cells, Cultured; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D015640:Ion Channel Gating; D008297:Male; D009157:Myasthenia Gravis / Q000097:blood / Q000276:immunology / Q000503:physiopathology*; D009469:Neuromuscular Junction / Q000502:physiology; D011978:Receptors, Nicotinic / Q000276:immunology / Q000502:physiology*; D012964:Sodium / Q000378:metabolism; D009435:Synaptic Transmission
D001323:Autoantibodies; D011978:Receptors, Nicotinic; D002217:Carbachol; D012964:Sodium; D000109:Acetylcholine